JP2003535564A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003535564A5 JP2003535564A5 JP2000512942A JP2000512942A JP2003535564A5 JP 2003535564 A5 JP2003535564 A5 JP 2003535564A5 JP 2000512942 A JP2000512942 A JP 2000512942A JP 2000512942 A JP2000512942 A JP 2000512942A JP 2003535564 A5 JP2003535564 A5 JP 2003535564A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- endogenous gene
- vector construct
- regulatory sequence
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 description 139
- 108090000623 proteins and genes Proteins 0.000 description 108
- 238000000034 method Methods 0.000 description 53
- 230000001105 regulatory effect Effects 0.000 description 52
- 230000035897 transcription Effects 0.000 description 34
- 238000013518 transcription Methods 0.000 description 34
- 230000014509 gene expression Effects 0.000 description 23
- 230000006801 homologous recombination Effects 0.000 description 20
- 238000002744 homologous recombination Methods 0.000 description 20
- 230000002103 transcriptional effect Effects 0.000 description 17
- 102000004169 proteins and genes Human genes 0.000 description 14
- 108010076504 Protein Sorting Signals Proteins 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 238000012216 screening Methods 0.000 description 8
- 230000003248 secreting effect Effects 0.000 description 8
- 108091081024 Start codon Proteins 0.000 description 7
- 238000012258 culturing Methods 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 230000006798 recombination Effects 0.000 description 6
- 239000002299 complementary DNA Substances 0.000 description 5
- 239000003623 enhancer Substances 0.000 description 5
- 238000005215 recombination Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 230000003827 upregulation Effects 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 4
- 239000003636 conditioned culture medium Substances 0.000 description 4
- 210000003527 eukaryotic cell Anatomy 0.000 description 4
- 230000014621 translational initiation Effects 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 2
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000007876 drug discovery Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 230000001177 retroviral effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 230000005026 transcription initiation Effects 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 108020005067 RNA Splice Sites Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94122397A | 1997-09-26 | 1997-09-26 | |
| US08/941,223 | 1997-09-26 | ||
| US15964398A | 1998-09-24 | 1998-09-24 | |
| US09/159,643 | 1998-09-24 | ||
| PCT/US1998/020094 WO1999015650A1 (en) | 1997-09-26 | 1998-09-25 | Expression of endogenous genes by non-homologous recombination of a vector construct with cellular dna |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003535564A JP2003535564A (ja) | 2003-12-02 |
| JP2003535564A5 true JP2003535564A5 (https=) | 2006-01-26 |
| JP5377806B2 JP5377806B2 (ja) | 2013-12-25 |
Family
ID=26856150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000512942A Expired - Lifetime JP5377806B2 (ja) | 1997-09-26 | 1998-09-25 | ベクター構築物の細胞ｄｎａとの非相同組換えによる内因性遺伝子の発現 |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1017803B1 (https=) |
| JP (1) | JP5377806B2 (https=) |
| KR (1) | KR20010024296A (https=) |
| CN (1) | CN100582230C (https=) |
| AT (1) | ATE471373T1 (https=) |
| AU (1) | AU750025B2 (https=) |
| BR (1) | BR9812540A (https=) |
| CA (1) | CA2304642C (https=) |
| DE (1) | DE69841723D1 (https=) |
| DK (1) | DK1017803T3 (https=) |
| IL (2) | IL135242A0 (https=) |
| NO (1) | NO20001497L (https=) |
| NZ (1) | NZ504185A (https=) |
| WO (1) | WO1999015650A1 (https=) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6740503B1 (en) | 1997-09-26 | 2004-05-25 | Athersys, Inc. | Compositions and methods for non-targeted activation of endogenous genes |
| US6897066B1 (en) | 1997-09-26 | 2005-05-24 | Athersys, Inc. | Compositions and methods for non-targeted activation of endogenous genes |
| WO2000049162A2 (en) * | 1999-02-19 | 2000-08-24 | Athersys, Inc. | Compositions and methods for non-targeted activation of endogenous genes |
| JP2003527833A (ja) | 1999-10-14 | 2003-09-24 | クロンテック・ラボラトリーズ・インコーポレーテッド | 花虫類に由来する発色団／蛍光体、およびそれらの使用法 |
| ES2391124T3 (es) | 2000-06-28 | 2012-11-21 | Amgen Inc. | Moléculas de receptor de linfopoyetina estromal tímica y usos de las mismas |
| GB0018876D0 (en) | 2000-08-01 | 2000-09-20 | Applied Research Systems | Method of producing polypeptides |
| AU2002227069A1 (en) * | 2000-10-30 | 2002-05-15 | Novozymes Biotech, Inc. | Methods for expressing endogenous genes by restriction enzyme mediated integration |
| AU2002343616A1 (en) | 2001-11-02 | 2003-05-19 | Athersys, Inc. | Methods for mutating genes in cells and animals using insertional mutagenesis |
| WO2003054158A2 (en) | 2001-12-19 | 2003-07-03 | The University Of Chicago | Rapidly maturing fluorescent proteins and methods for using the same |
| US7662924B2 (en) | 2002-02-22 | 2010-02-16 | The Board Of Trustees Of The University Of Illinois | Beta chain-associated regulator of apoptosis |
| DK1534819T3 (da) | 2002-08-21 | 2010-04-19 | Revivicor Inc | Griselignende dyr, som mangler enhver ekspression af funktionel alfa-1,3-galactosyltransferase |
| US9453251B2 (en) | 2002-10-08 | 2016-09-27 | Pfenex Inc. | Expression of mammalian proteins in Pseudomonas fluorescens |
| US8021833B2 (en) | 2003-02-12 | 2011-09-20 | Functional Genetics, Inc. | Method for reducing HIV viral budding by administering a VPS28-specfic antibody that disrupts Gag-TSG101-VPS28 binding interactions |
| US11311574B2 (en) | 2003-08-08 | 2022-04-26 | Sangamo Therapeutics, Inc. | Methods and compositions for targeted cleavage and recombination |
| US7888121B2 (en) | 2003-08-08 | 2011-02-15 | Sangamo Biosciences, Inc. | Methods and compositions for targeted cleavage and recombination |
| US8409861B2 (en) | 2003-08-08 | 2013-04-02 | Sangamo Biosciences, Inc. | Targeted deletion of cellular DNA sequences |
| AU2005223617A1 (en) | 2004-03-17 | 2005-09-29 | Revivicor, Inc. | Tissue products from animals lacking functional alpha 1,3 galactosyl transferase |
| EP1732944B1 (en) | 2004-04-07 | 2012-09-05 | The University of Chicago | Monomeric red fluorescent proteins |
| BRPI0513826A2 (pt) | 2004-07-26 | 2010-06-22 | Dow Global Technologies Inc | processo para expressão de proteìna melhorada através de engenharia de cepa |
| CA2958259C (en) | 2004-10-22 | 2020-06-30 | Revivicor, Inc. | Ungulates with genetically modified immune systems |
| PA8660701A1 (es) | 2005-02-04 | 2006-09-22 | Pfizer Prod Inc | Agonistas de pyy y sus usos |
| EP1891107B1 (en) | 2005-05-12 | 2011-07-06 | ZymoGenetics, Inc. | Compositions and methods for modulating immune responses |
| EP3138403A1 (en) | 2005-08-09 | 2017-03-08 | Revivicor, Inc. | Transgenic ungulates expressing ctla4-ig and uses thereof |
| WO2007053732A2 (en) | 2005-11-01 | 2007-05-10 | Mayo Foundation For Medical Education And Research | Promoter polymorphisms of the blys gene and use in diagnostic methods |
| US8014957B2 (en) | 2005-12-15 | 2011-09-06 | Fred Hutchinson Cancer Research Center | Genes associated with progression and response in chronic myeloid leukemia and uses thereof |
| CN101511868B (zh) | 2006-07-24 | 2013-03-06 | 比奥雷克西斯制药公司 | 毒蜥外泌肽融合蛋白 |
| US9580719B2 (en) | 2007-04-27 | 2017-02-28 | Pfenex, Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
| US9394571B2 (en) | 2007-04-27 | 2016-07-19 | Pfenex Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
| WO2009059305A2 (en) | 2007-11-01 | 2009-05-07 | The University Of Chicago | Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation |
| WO2009073511A2 (en) | 2007-11-30 | 2009-06-11 | Mayo Foundation For Medical Education And Research | Polymorphisms of the blys gene and use in diagnostic methods |
| EP2525808A2 (en) | 2010-01-19 | 2012-11-28 | The Trustees Of Columbia University In The City Of New York | Osteocalcin as a treatment for male reproductive disorders |
| CN102669057B (zh) * | 2011-03-18 | 2014-11-26 | 上海南方模式生物科技发展有限公司 | 一种调控动物内源基因表达的遗传修饰方法 |
| KR101948248B1 (ko) * | 2011-11-18 | 2019-02-14 | 한국생명공학연구원 | 단백질 발현 미세 조절방법 |
| US9957515B2 (en) | 2013-03-15 | 2018-05-01 | Cibus Us Llc | Methods and compositions for targeted gene modification |
| WO2014152497A2 (en) | 2013-03-15 | 2014-09-25 | The Trustees Of Columbia University In The City Of New York | Osteocalcin as a treatment for cognitive disorders |
| KR102450868B1 (ko) * | 2014-03-14 | 2022-10-06 | 시버스 유에스 엘엘씨 | 올리고뉴클레오타이드 매개 유전자 보수를 사용한 표적화된 유전자 변형의 효율을 증가시키기 위한 방법 및 조성물 |
| JP7175608B2 (ja) | 2014-11-19 | 2022-11-21 | ザ トラスティーズ オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク | 加齢に伴うフレイルのための治療としてのオステオカルシン |
| CA3100376A1 (en) | 2018-05-15 | 2019-11-21 | Duke University | Systems and methods for genetic manipulation of akkermansia species |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5024939A (en) * | 1987-07-09 | 1991-06-18 | Genentech, Inc. | Transient expression system for producing recombinant protein |
| EP0945515A3 (en) * | 1989-11-06 | 2002-08-21 | Cell Genesys, Inc. | Production of proteins using homologous recombination |
| US5204939A (en) * | 1989-12-14 | 1993-04-20 | Fujitsu Limited | Rule base processing system and rule evaluation control method therein |
| US5272071A (en) * | 1989-12-22 | 1993-12-21 | Applied Research Systems Ars Holding N.V. | Method for the modification of the expression characteristics of an endogenous gene of a given cell line |
| US6270989B1 (en) * | 1991-11-05 | 2001-08-07 | Transkaryotic Therapies, Inc. | Protein production and delivery |
| US5641670A (en) * | 1991-11-05 | 1997-06-24 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
| US5561053A (en) * | 1994-08-05 | 1996-10-01 | Genentech, Inc. | Method for selecting high-expressing host cells |
| WO2000049162A2 (en) * | 1999-02-19 | 2000-08-24 | Athersys, Inc. | Compositions and methods for non-targeted activation of endogenous genes |
-
1998
- 1998-09-25 IL IL13524298A patent/IL135242A0/xx unknown
- 1998-09-25 CA CA2304642A patent/CA2304642C/en not_active Expired - Lifetime
- 1998-09-25 AU AU95816/98A patent/AU750025B2/en not_active Expired
- 1998-09-25 DK DK98949508.0T patent/DK1017803T3/da active
- 1998-09-25 NZ NZ504185A patent/NZ504185A/xx unknown
- 1998-09-25 DE DE69841723T patent/DE69841723D1/de not_active Expired - Lifetime
- 1998-09-25 CN CN98811571A patent/CN100582230C/zh not_active Expired - Lifetime
- 1998-09-25 BR BR9812540-0A patent/BR9812540A/pt not_active IP Right Cessation
- 1998-09-25 KR KR1020007003195A patent/KR20010024296A/ko not_active Ceased
- 1998-09-25 JP JP2000512942A patent/JP5377806B2/ja not_active Expired - Lifetime
- 1998-09-25 EP EP98949508A patent/EP1017803B1/en not_active Expired - Lifetime
- 1998-09-25 WO PCT/US1998/020094 patent/WO1999015650A1/en not_active Ceased
- 1998-09-25 AT AT98949508T patent/ATE471373T1/de not_active IP Right Cessation
-
2000
- 2000-03-22 NO NO20001497A patent/NO20001497L/no not_active Application Discontinuation
- 2000-03-23 IL IL135242A patent/IL135242A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003535564A5 (https=) | ||
| D'Adamio et al. | Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24.11): multiple miniexons and separate 5'untranslated regions. | |
| Williams et al. | Isolation of a hamster cDNA clone coding for a function involved in methotrexate uptake. | |
| Cooper et al. | Identification and characterization of Uss1p (Sdb23p): a novel U6 snRNA‐associated protein with significant similarity to core proteins of small nuclear ribonucleoproteins. | |
| Haeuptle et al. | A tripartite structure of the signals that determine protein insertion into the endoplasmic reticulum membrane. | |
| JP7418469B2 (ja) | アミエロイス由来のトランスポザーゼを用いた核酸コンストラクトの真核生物のゲノムへの転移 | |
| Karpel et al. | Overexpression of alternative human acetylcholinesterase forms modulates process extensions in cultured glioma cells | |
| US6100025A (en) | Cloning by complementation and related processes | |
| JP2021534798A (ja) | ゲノムを調節するための方法及び組成物 | |
| Baasiri et al. | Overlapping functions for two G protein α subunits in Neurospora crassa | |
| KR20010099682A (ko) | 단일가닥 ｄｎａ의 효소 합성 | |
| WO1996003519A1 (en) | Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same | |
| Choi et al. | Identification of a novel isoform of the cyclic-nucleotide phosphodiesterase PDE3A expressed in vascular smooth-muscle myocytes | |
| EP0941320A2 (en) | Human proteins having transmembrane domains and dnas encoding these proteins | |
| Tsumaki et al. | Separable cis-regulatory elements that contribute to tissue-and site-specific alpha 2 (XI) collagen gene expression in the embryonic mouse cartilage. | |
| US5932465A (en) | Phosphodiesterase 8A | |
| JP2001503962A (ja) | 細胞のゲノム中に組込まれる付加核酸物質を細胞に付与するためのベクターおよび方法 | |
| Van Raay et al. | A novel ribosomal protein L3-like gene (RPL3L) maps to the autosomal dominant polycystic kidney disease gene region | |
| Dou et al. | Structure and Organization of the HumanNeuronatinGene | |
| Kato et al. | Molecular cloning and expression of mouse Mg2+-dependent protein phosphatase β-4 (type 2Cβ-4) | |
| AU721105B2 (en) | Mammalian regulator of nonsense-mediated RNA decay | |
| Ambartsumian et al. | Characterization of two splice variants of metastasis-associated human mts1 gene | |
| Lin et al. | Differential regulation of human T-plastin gene in leukocytes and non-leukocytes: identification of the promoter, enhancer, and CpG island | |
| JP4528446B2 (ja) | 前立腺特異的膜抗原遺伝子のイントロン３を含む調節構築物 | |
| JP2002506345A (ja) | 植物ｇｒａｂタンパク質 |